MDT - Medtronic plc


76.82
2.280   2.968%

Share volume: 10,252,160
Last Updated: 05-12-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$74.54
2.28
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
44%
Profitability 37%
Dept financing 21%
Liquidity 25%
Performance 62%
Company vs Stock growth
vs
Performance
5 Days
0.88%
1 Month
-12.70%
3 Months
-22.79%
6 Months
-20.10%
1 Year
-9.74%
2 Year
-8.02%
Key data
Stock price
$76.82
P/E Ratio 
28.04
DAY RANGE
$74.60 - $77.12
EPS 
$3.59
52 WEEK RANGE
$74.40 - $106.33
52 WEEK CHANGE
-$8.82
MARKET CAP 
129.330 B
YIELD 
2.81%
SHARES OUTSTANDING 
1.284 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,413,468
AVERAGE 30 VOLUME 
$9,564,205
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news